2MM: AI Roundup- AI Cancer Test, Smarter Hospitals, Faster Drug Discovery, and Mental Health Tech [May 2nd, 2025]

AI Blood Test Could Replace Colonoscopies

Forget the prep kits and uncomfortable procedures—there’s a new blood test that might change how we screen for cancer. The UK’s NHS is running a clinical trial for miONCO-Dx, an AI-powered test developed by the University of Southampton and startup Xgenera. Using just 10–15 drops of blood, it aims to detect 12 common cancers with 99% accuracy, based on trials involving 20,000 patients.

This could eliminate the need for invasive tools like colonoscopies and biopsies. Backed by £2.4 million in government funding, the trial will include 8,000 patients and is part of the UK’s National Cancer Plan to push early detection through tech. Health Secretary Wes Streeting called attention to the life-saving potential of early diagnosis, referencing the late Dame Deborah James, who helped raise £11 million for cancer research. A lab named in her honor at the Francis Crick Institute will lead follow-up research. Researchers shared on April 30 that the first wave of blood samples is now under analysis, with early indicators described as “encouraging” by the study’s lead scientist.

To read more, visit: BBC – Cancer blood test trial launches

Virtual Nursing at Emory Gets AI Upgrade

Emory Healthcare has rolled out a virtual nursing program that combines AI tech with bedside care at Emory University Hospital Midtown. Nurses are now supported by telehealth tools and AI systems that handle routine tasks like admissions paperwork and medication reminders. More impressively, LIDAR sensors track patient movement and warn staff up to 30 seconds before a possible fall, helping prevent injuries. This approach frees up nurses to spend more time on direct care and less on admin, with expansion plans covering eight inpatient units by year-end. The system is part of Emory’s larger digital transformation strategy to build smarter, safer hospitals. The initiative aligns with nationwide nursing shortages by aiming to extend staff bandwidth without sacrificing care quality.

In a newly released progress report dated April 29, Emory noted a 21% drop in fall-related incidents since the system’s implementation, prompting internal teams to scale deployment faster than initially planned.

To read more, visit: HealthTech Magazine – Emory virtual nursing

Insilico’s $110M AI Bet on Drug Discovery

Insilico Medicine just secured $110 million in Series E funding to boost its AI-powered drug discovery platform, Pharma.AI. The company uses generative AI to speed up the development of treatments for conditions like cancer and age-related diseases. Their standout achievement: designing a molecule for idiopathic pulmonary fibrosis in just 18 months—less than half the usual time and at a fraction of the cost. The funding will expand their robotic labs, proprietary algorithms, and drug pipeline. With this momentum, Insilico aims to position itself as a major player in reshaping biotech’s R&D cycle. Pharma.AI analyzes biological data, predicts drug-target interactions, and generates novel compound structures—bringing speed and scale to a slow, expensive process. At a May 1 press briefing, the company confirmed that two AI-developed cancer therapies are on track to enter Phase I trials this fall, following strong preclinical data presented at BioAsia.

To read more, visit: Fierce Biotech – Insilico raises $110M

AI Chatbots Are Boosting Mental Health Outcomes

AI chatbots may be doing more than just checking in. Now, they’re also helping people heal! A peer-reviewed study focused on Limbic Care, a generative AI companion that supports cognitive behavioral therapy across five NHS Talking Therapies sites. The results are striking: a 42% increase in therapy attendance and a 25% jump in recovery rates compared to traditional care models. Limbic helps therapists tailor sessions with real-time feedback and supports users between appointments through gentle nudges and CBT tools. It’s the first autonomous GenAI mental health tool to be studied in real-world NHS settings, and experts say it could serve as a model for wider implementation. The program has seen growing interest across the UK as a tool to alleviate long waitlists and clinician burnout. On April 30, the team behind Limbic announced a multilingual rollout designed to make therapy more accessible for non-English speaking patients in cities like Birmingham, Manchester, and London.

To read more, visit: Digital Health – Limbic’s AI chatbot improves access

New AI App Monitors Kids’ Mental Health

Aura, an AI-powered mental health app, is helping parents detect emotional distress in their children by quietly analyzing online behavior. The app looks at screen time patterns, mood indicators, and social media shifts to flag potential issues like anxiety or suicidal ideation. Priced at $32 per month for families, it also gives parents prompts for how to talk to their kids about what’s going on. The goal isn’t surveillance, it’s early intervention. Developers emphasize the app is meant to spark helpful conversations, not replace them. It’s one of several tools aiming to meet the rising demand for digital mental health solutions in children and teens. In late April, Aura released user stats showing an uptick in alerts tied to disrupted sleep and negative online peer interactions—insights the company says will shape new parental guidance tools launching in May.

To read more, visit:  Aura Introduces AI-Powered Tools to Take on Youth Mental Health Crisis

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.